Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07830823Completed
Randomised, open-label trial (4 arms), sponsored by First People's Hospital of Lin'an District, Hangzhou. Primary endpoints: Serum inflammatory factors and pain mediators (IL-1β, IL-6, and PGE2) and Visual Analog Scale Pain Score. Started Nov 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07830823.